Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study

Overview

The purpose of this study is to investigate the demographic characteristics, clinical features, diagnoses and treatments of AECOPD hospitalized patients in China, and disease prognosis and its economic burden.

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 2016

Clinical Trial Outcome Measures

Primary Measures

  • In-hospital mortality
    • Time Frame: 12 months
    • All-cause and cause-specific mortality will be described.
  • Readmission
    • Time Frame: 12 months
    • Readmission rate caused by AECOPD within 1 month after discharged from hospital.

Secondary Measures

  • All-cause and cause-specific mortality
    • Time Frame: 3 years
    • All-cause and cause-specific mortality will be described at different time points (1, 2, 3 years)
  • Recurrence of acute exacerbation of COPD
    • Time Frame: 3 years
    • Frequency of AECOPD recurrence will be described during follow-ups, the date of first recurrence after discharge will be analysed.
  • Lung function and quality of life assessment
    • Time Frame: 3 years
    • Lung function will be measured regularly, quality of life will be assessed by questionnaires
  • Healthcare costs
    • Time Frame: 12 months
    • Direct costs of hospital stay will be recorded.

Participating in This Clinical Trial

Inclusion Criteria

≥18 years of age; hospitalized patients with main diagnosis as AECOPD. Exclusion Criteria:

Patients diagnosed as active pulmonary tuberculosis, or acute left heart failure; Patients participating in clinical trials or intervention studies of drugs.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • China-Japan Friendship Hospital
  • Collaborator
    • Peking University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Chen Wang, Prof.Dr. – China-Japan Friendship Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.